{"public_id":"cl_20a62a8bb80ee7865d981a4ed25ed013","status":"active","superseded_by_public_id":null,"corpus_id":131780051,"text":"Only around 50% of DCIS is believed to progress to invasive carcinoma, meaning many DCIS patients are likely being overtreated with surgery.","confidence":0.85,"paper":{"corpus_id":131780051,"title":"A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast","url":"https://sah.borca.ai/papers/131780051"},"contributors":[{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["extraction"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["review"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_051c2dff4b8b2627a98b44015753efdb","name":"overtreatment","description":"Unnecessary surgical treatment of DCIS patients whose disease would not have progressed to invasive carcinoma.","types":["concept"],"url":"https://sah.borca.ai/concepts/co_051c2dff4b8b2627a98b44015753efdb"},{"public_id":"co_af5ed857ca0a8edd3aa3eff3146894c2","name":"invasive carcinoma","description":"The malignant progression from DCIS to invasive breast cancer that only approximately half of DCIS cases are believed to reach.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_af5ed857ca0a8edd3aa3eff3146894c2"},{"public_id":"co_fb79cbf0671b49e907e55ce6ad45a418","name":"ductal carcinoma in situ","description":"A nonobligate precursor of invasive breast cancer accounting for 20% of screen-detected breast cancers, most often treated surgically despite only around 50% progression risk.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_fb79cbf0671b49e907e55ce6ad45a418"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_20a62a8bb80ee7865d981a4ed25ed013"}